Pro-inflammatory IL-8 is a potential indicator of poor outcome in patients with advanced melanoma treated with immune checkpoint inhibitors and it is associated with higher tumor grading and staging (4, 11, 12). This evidence concerns the gene CXCL8 and melanoma.